Assenagon Asset Management S.A. Has $13.88 Million Stock Position in Maximus, Inc. (NYSE:MMS)

Assenagon Asset Management S.A. raised its position in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 45.3% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 203,561 shares of the health services provider's stock after buying an additional 63,446 shares during the quarter. Assenagon Asset Management S.A. owned 0.36% of Maximus worth $13,881,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock valued at $488,829,000 after buying an additional 205,564 shares in the last quarter. Mackenzie Financial Corp lifted its stake in Maximus by 2.0% during the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock valued at $207,687,000 after buying an additional 55,583 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after buying an additional 177,075 shares in the last quarter. Van Berkom & Associates Inc. lifted its stake in Maximus by 8.5% during the fourth quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider's stock valued at $93,792,000 after buying an additional 98,264 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its holdings in shares of Maximus by 7.4% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after purchasing an additional 84,835 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Maximus

In other Maximus news, Director Jan Madsen sold 2,439 shares of the stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the transaction, the director now owns 18,097 shares in the company, valued at $1,225,347.87. This trade represents a 11.88% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Gayathri Rajan sold 7,913 shares of the stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the transaction, the director now owns 14,205 shares in the company, valued at approximately $1,028,157.90. This trade represents a 35.78% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

Maximus Stock Down 1.8%

Shares of MMS traded down $1.30 during trading hours on Friday, reaching $69.66. The company's stock had a trading volume of 331,547 shares, compared to its average volume of 568,670. The firm has a market cap of $3.93 billion, a price-to-earnings ratio of 14.98 and a beta of 0.62. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The company has a 50 day moving average of $70.45 and a two-hundred day moving average of $71.17.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm's quarterly revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.57 EPS. As a group, research analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Saturday, May 31st. Investors of record on Thursday, May 15th were given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend was Thursday, May 15th. Maximus's payout ratio is presently 23.86%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.